Posted On: 11/25/2015 10:54:01 AM
Post# of 72443
Stating the obvious: data was supplied to the FDA to support this fast-track status. We know that the enrollment in the trial is proceeding quickly.
Obviously -- there are promising results so far that WE haven't seen but that the people that matter HAVE seen.
I think it's very conservative to think that 150,000 people a year would use Bril-OM if available. It might become routine for all patients with chemo to use it.
Obviously -- there are promising results so far that WE haven't seen but that the people that matter HAVE seen.
I think it's very conservative to think that 150,000 people a year would use Bril-OM if available. It might become routine for all patients with chemo to use it.
(0)
(0)Scroll down for more posts ▼
